Logo image of PBTS

POWERBRIDGE TECHNOLOGIES CO (PBTS) Stock Fundamental Analysis

NASDAQ:PBTS - Nasdaq - KYG720071268 - Common Stock - Currency: USD

1.1  +0.08 (+7.32%)

After market: 1.1 0 (0%)

Fundamental Rating

1

PBTS gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 285 industry peers in the Software industry. PBTS has a bad profitability rating. Also its financial health evaluation is rather negative. PBTS is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year PBTS has reported negative net income.
In the past 5 years PBTS reported 4 times negative net income.
In multiple years PBTS reported negative operating cash flow during the last 5 years.
PBTS Yearly Net Income VS EBIT VS OCF VS FCFPBTS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 0 5M -5M -10M -15M -20M

1.2 Ratios

PBTS has a Return On Assets of -34.89%. This is in the lower half of the industry: PBTS underperforms 73.74% of its industry peers.
PBTS has a worse Return On Equity (-65.55%) than 67.27% of its industry peers.
Industry RankSector Rank
ROA -34.89%
ROE -65.55%
ROIC N/A
ROA(3y)-13.93%
ROA(5y)-14.32%
ROE(3y)-19.07%
ROE(5y)-43.18%
ROIC(3y)N/A
ROIC(5y)N/A
PBTS Yearly ROA, ROE, ROICPBTS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 0 100 -100 200 300

1.3 Margins

Looking at the Gross Margin, with a value of 41.27%, PBTS is doing worse than 73.38% of the companies in the same industry.
In the last couple of years the Gross Margin of PBTS has remained more or less at the same level.
PBTS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 41.27%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.06%
GM growth 5Y-0.78%
PBTS Yearly Profit, Operating, Gross MarginsPBTS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 0 -50 -100 -150 -200

2

2. Health

2.1 Basic Checks

PBTS does not have a ROIC to compare to the WACC, probably because it is not profitable.
PBTS has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, PBTS has a worse debt to assets ratio.
PBTS Yearly Shares OutstandingPBTS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2M 4M 6M 8M
PBTS Yearly Total Debt VS Total AssetsPBTS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M 100M

2.2 Solvency

PBTS has an Altman-Z score of -1.14. This is a bad value and indicates that PBTS is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of PBTS (-1.14) is worse than 77.70% of its industry peers.
PBTS has a Debt/Equity ratio of 0.10. This is a healthy value indicating a solid balance between debt and equity.
With a Debt to Equity ratio value of 0.10, PBTS perfoms like the industry average, outperforming 53.96% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF N/A
Altman-Z -1.14
ROIC/WACCN/A
WACC6.21%
PBTS Yearly LT Debt VS Equity VS FCFPBTS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 0 20M 40M 60M 80M 100M

2.3 Liquidity

PBTS has a Current Ratio of 1.07. This is a normal value and indicates that PBTS is financially healthy and should not expect problems in meeting its short term obligations.
PBTS's Current ratio of 1.07 is on the low side compared to the rest of the industry. PBTS is outperformed by 74.82% of its industry peers.
A Quick Ratio of 1.07 indicates that PBTS should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.07, PBTS is not doing good in the industry: 72.66% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.07
Quick Ratio 1.07
PBTS Yearly Current Assets VS Current LiabilitesPBTS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M

0

3. Growth

3.1 Past

PBTS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -496.21%.
The Revenue for PBTS has decreased by -60.56% in the past year. This is quite bad
Measured over the past years, PBTS shows a very negative growth in Revenue. The Revenue has been decreasing by -13.49% on average per year.
EPS 1Y (TTM)-496.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-457.95%
Revenue 1Y (TTM)-60.56%
Revenue growth 3Y-19.51%
Revenue growth 5Y-13.49%
Sales Q2Q%-6.2%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PBTS Yearly Revenue VS EstimatesPBTS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M
PBTS Yearly EPS VS EstimatesPBTS Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 0 5 -5 -10 -15

0

4. Valuation

4.1 Price/Earnings Ratio

PBTS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PBTS Price Earnings VS Forward Price EarningsPBTS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PBTS Per share dataPBTS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20 -20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

PBTS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

POWERBRIDGE TECHNOLOGIES CO

NASDAQ:PBTS (1/29/2024, 8:27:35 PM)

After market: 1.1 0 (0%)

1.1

+0.08 (+7.32%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)N/A N/A
Earnings (Next)12-29 2022-12-29/amc
Inst Owners7.93%
Inst Owner Change-68.68%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap5.14M
Analysts82.86
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.51
P/FCF N/A
P/OCF N/A
P/B 0.05
P/tB 0.08
EV/EBITDA N/A
EPS(TTM)-22.48
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS2.15
BVpS23.02
TBVpS13.45
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -34.89%
ROE -65.55%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 41.27%
FCFM N/A
ROA(3y)-13.93%
ROA(5y)-14.32%
ROE(3y)-19.07%
ROE(5y)-43.18%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.06%
GM growth 5Y-0.78%
F-ScoreN/A
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.07
Quick Ratio 1.07
Altman-Z -1.14
F-ScoreN/A
WACC6.21%
ROIC/WACCN/A
Cap/Depr(3y)177.66%
Cap/Depr(5y)235.15%
Cap/Sales(3y)19.41%
Cap/Sales(5y)16.4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-496.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-457.95%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-60.56%
Revenue growth 3Y-19.51%
Revenue growth 5Y-13.49%
Sales Q2Q%-6.2%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-178.29%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y7.65%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y1.02%
OCF growth 3YN/A
OCF growth 5YN/A